A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer

Radiotherapy and Oncology

Volumn 70, Issue 1, 2004, Pages 37-44

  Bayley, Andrew John ^a,b   Catton, Charles Nicholas ^a   Haycocks, Tara ^a   Kelly, Valerie ^a   Alasti, Hamideh ^a   Bristow, Robert ^a   Catton, Pamela ^a   Crook, Juanita ^a   Gospodarowicz, Mary Krystyna ^a   McLean, Michael ^a   Milosevic, Michael ^a   Warde, Pardraig ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Conformal radiotherapy; Prostate cancer; Treatment position

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BLADDER WALL; BODY POSTURE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMOBILIZATION; INTESTINE WALL; MALE; PATIENT POSITIONING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RECTUM; SIMULATION; SMALL INTESTINE; STATISTICAL SIGNIFICANCE; SUPINE POSITION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 10744222251     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.08.007     Document Type: Article

References (35)

1. Antolak J., Rosen I.I., Childress C., Zagers G., Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;661-672.
2. Balter J., Sandler H.M., Lam K., Bree R.L., Lichter A.S., Ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys. 31:1995;113-118.
3. Beard C., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys. 34:1996;451-458.
4. Bentel G., Munley M., Marks L., Anscher M. The effect of pressure from the table top and patient position on pelvic organ location in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 47:1999;247-253.
5. Crook J., Raymond Y., Salhani D. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol. 37:1995;35-42.
6. Dawson L., Litzenberg D.W., Brock K.K., Sanda M. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys. 48:2000;319-323.
7. Dearnaley D.P., Khoo V.S., Norman A.R. Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet. 353:1999;267-272.
8. Forman J., Duclos M., Shamsa F., Porter A.T., Orton C. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. Int J Radiat Oncol Biol Phys. 34:1996;655-662.
9. Forman J.D., Messina C.F., He T., et al. Evaluation of changes in the location and shape of the prostate and rectum during a seven week course of conformal radiotherapy (Abstr.). Int J Radiat Oncol Biol Phys. 27:1993;222.
10. Gallagher M., Brereton H., Rostock R., et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys. 12:1986;1565-1573.
11. Haken T., Forman J.D., Heimburger D.K., Gerhardssow A. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 20:1991;1317-1324.
12. Hanks G., Lee W., Hanlon A., Hunt M., Kaplan E., Epstein B. Conformal techniques dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher dose in patients with pre-treatment prostate specific antigen >10 ng/ml. Int J Radiat Oncol Biol Phys. 35:1998;862-868.
13. Hanley J., Lumley M., Mageras G., Sun J. Measurement of patient positioning errors in three dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys. 37:1997;435-444.
14. ICRUReport (No 62). Bethesda: International Commission on Radiation Units and Measurement; 1999.
15. Kitamura K., Shirato H., Seppenwoolde Y., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys. 53:2002;1117-1123.
16. Leibel S., Zelefsky M., Kutcher G., et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol. 21:1994;580-597.
17. Malone S., Crook J., Kendal W., Szanto J. Respiratory-induced prostate motion: quantification and characterisation. Int J Radiat Oncol Biol Phys. 48:2000;105-109.
18. Malone S., Szanto J., Perry G., Gerig L., Dahrouge S., Crook J. A prospective comparison of three systems of patient immobilization for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;657-665.
19. McLaughlin P.W., Wygoda A., Shahijdak W., Sandler H.M. The effect of patient positioning and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;407-413.
20. Melian E., Kutcher G., Leibel S., Zelefsky M., Baldwin B., Fuks Z. Variation in prostate motion quantification and implications for three dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 27:1993;137.
21. Nutting C.M., Khoo V.S., Walker V., et al. A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol. 54:2000;1-9.
22. Pollack A., Zagars G.K., Smith L.G., Lee J.J. Preliminary results of a randomized radiotherapy dose escalation study comparing 70 with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
23. Rudat V., Schraube P., Oetzel D., Zierhut D. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;1027-1034.
24. Sandler H., Perez-Tamayo C., Ten Haken R., Lichter A. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol. 23:1992;53-54.
25. Schild S., Casale H., Bellafontaine L. Movements of the prostate due to rectal and bladder distension: implications for radiotherapy. Med Dosimetry. 18:1993;13-15.
26. Shipley W., Verhey L., Munzenrider J., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 32:1995;2-12.
27. Soffen E., Hanks G., Hunt M., Epstein B. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity. Int J Radiat Oncol Biol Phys. 24:1992;485-488.
28. Stroom J., Koper P., Korevaar G., van Os M. Internal organ motion in prostate cancer patients treated in prone and supine treatment positions. Radiother Oncol. 51:1999;237-248.
29. Tinger A., Michalski J.M., Cheng A., Low D. A critical evaluation of the planning target volume for 3D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;213-221.
30. van Herk M., Bruce A., Kroes A., Shouman T., Touw A., Lebesque J. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 33:1995;1311-1320.
31. Weber D., Nouet P., Rouzaud M., Mirabell R. Patient positioning in prostate radiotherapy: is prone better than supine? Int J Radiat Oncol Biol Phys. 47:2000;365-371.
32. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre setup verification and implanted prostate markers. Radiother Oncol. 61:2001;127-133.
33. Zelefsky M., Crean D., Mageras G., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol. 50:1999;225-234.
34. Zelefsky M., Happerset I., Liebel S.A., Burman C.M. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 37:1997;13-19.
35. Zelefsky M., Leibel S., Kutcher G., Kelson S., Ling C., Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Can J Sci Am. 1:1995;42-50.